eToro Group Ltd. announced its Q3 2026 results showing an 18% year-over-year increase in funded accounts to 4.39 million and assets under administration steady at $20.8 billion. Despite a 13% drop in net contribution and a 74% decline in GAAP net income due to reduced crypto trading, the company launched a new AI-driven app and expanded 24/7 trading. eToro also initiated a $250 million share repurchase program, signaling confidence in its long-term growth and financial strength. The company plans to continue investing in platform innovation and expand its presence, including through the acquisition of Argentine fintech LB Finanzas.
eToro's Q3 2026 results provide context for readers following financial technology developments. For readers following Financials-sector US stocks on Pluang, here is the market snapshot as of Nov 10, 2026 18:42 WIB: out of 142 priced stocks, 90 rose and 45 fell. Notable movers include PSEC at USD 1.54 with a 1-day change of +1.99% and 80% buy orders, ING at USD 33.75 with a 1-day change of +1.66%, and RIOT at USD 17.95 with a 1-day change of +1.61% but 74% sell orders.
The 2026 Verizon Data Breach Investigations Report links 61% of manufacturing breaches to third parties and 81% to internal data compromise. Manufacturers adopting Microsoft 365 Copilot should carefully manage which engineering and supplier files emp...
Soleo Health has been selected as a specialty pharmacy partner for Pasatru™ (garetosmab-grts), Regeneron's FDA-approved treatment for adults with fibrodysplasia ossificans progressiva (FOP), an ultra-rare genetic disorder. Pasatru™ is the first treat...
PsiThera raised $25 million in financing led by new investors AbbVie Ventures and Lumination Capital, alongside existing backers. The funds will support development of its oral small molecule TNFα inhibitor and advance its oral TL1A inhibitors into l...
Opus Genetics announced its Q3 2026 financial results and significant progress in its gene therapy programs for inherited retinal diseases. Key milestones include completion of dosing in OPGx-BEST1 Cohort 2 with data expected in Q1 2027, full enrollm...
Iveco Group is exhibiting its latest products, including new light and heavy-duty vehicles powered by FPT engines, at Fenatran 2026 in São Paulo, highlighting its strong industrial and commercial presence in Latin America. The event marks the regiona...
